Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships
Dr Trilla will apply the knowledge gained from his experience collaborating on over 160 life science partnerships to oversee corporate strategy, business partnerships and lead Intrommune through our business planning process.
- Dr Trilla will apply the knowledge gained from his experience collaborating on over 160 life science partnerships to oversee corporate strategy, business partnerships and lead Intrommune through our business planning process.
- I am confident that my background as a licensed physician and global entrepreneur distinguishes me as an ideal leader for Intrommune, said Sergi Trilla, MD, MBA, Director of Corporate Strategy & Partnerships, Intrommune.
- My decades of life science business experience will help advance Intrommune and its OMIT food allergy technology platform.
- My expertise in international healthcare business also provides a perspective to help Intrommune in its global product and corporate development and partnerships, added Trilla.